Mediclinic International (Mediclinic International) EBIT : $351 Mil (TTM As of Sep. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International EBIT?

Mediclinic International's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2022 was $152 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was $351 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mediclinic International's annualized ROC % for the quarter that ended in Sep. 2022 was 3.28%. Mediclinic International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was 5.14%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Mediclinic International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was 8.66%.

Mediclinic International EBIT Historical Data

The historical data trend for Mediclinic International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International EBIT Chart

Mediclinic International Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

EBIT

Get a 7-Day Free Trial

-583.80

-108.04

-242.57

231.62

361.00

Mediclinic International Semi-Annual Data
	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22
EBIT	Get a 7-Day Free Trial															67.36	159.50	168.96	198.95	151.76

Competitive Comparison of Mediclinic International's EBIT

For the Medical Care Facilities subindustry, Mediclinic International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mediclinic International's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mediclinic International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mediclinic International's EV-to-EBIT falls into.

Mediclinic International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $351 Mil.

Mediclinic International (OTCPK:ANHGY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mediclinic International's annualized ROC % for the quarter that ended in Sep. 2022 is calculated as:

	ROC % (Q: Sep. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2022 )	+	Invested Capital (Q: Sep. 2022 ))	/ count )
=	269.536 * ( 1 - 4.21% )	/	( (8061.924	+	7703.284)	/ 2 )
=	258.1885344	/	7882.604
=	3.28 %

where

	Invested Capital		(Q: Mar. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	9495.389	-	722.003	-	( 711.462	-	max(0, 1084.321	-	1942.029	+	711.462	))
=	8061.924

	Invested Capital		(Q: Sep. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8926.387	-	708.947	-	( 514.156	-	max(0, 1183.465	-	1758.777	+	514.156	))
=	7703.284

Note: The Operating Income data used here is two times the semi-annual (Sep. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Mediclinic International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2022		Q: Sep. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	303.51	/	( ( (5777.339 + max(301.714, 0))	+	(5434.881 + max(306.909, 0)) )	/	2 )
=	303.51	/	( ( 6079.053	+	5741.79 )	/	2 )
=	303.51	/	5910.4215
=	5.14 %

where Working Capital is:

	Working Capital		(Q: Mar. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(951.252	+	127.8	+	81.687)	-	(722.003	+	0	+	137.022)
=	301.714

	Working Capital		(Q: Sep. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1116.648	+	123.443	+	4.5300000000002)	-	(708.947	+	0	+	228.765)
=	306.909

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Mediclinic International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2022 )
	=	350.701	/	4047.448
	=	8.66 %

Mediclinic International EBIT Related Terms

Thank you for viewing the detailed overview of Mediclinic International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mediclinic International (Mediclinic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.mediclinic.com

Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.